Titan Pharmaceuticals, Inc. Restricted Cash
Titan Pharmaceuticals, Inc. had Restricted Cash of $13.00 thousand as of 2023-12-31, per its 10-K filed 2025-03-20.
Financial Statements › Balance Sheet › Assets
us-gaap:RestrictedCash · last filed 2025-03-20
- 2023-12-31: Restricted Cash $13.00K.
- 2023-09-30: Restricted Cash $13.00K.
- 2023-06-30: Restricted Cash $17.00K.
- 2023-03-31: Restricted Cash $98.00K.
| Period end | Restricted Cash |
|---|---|
| 2023-12-31 | $13.00K 10-K · filed 2025-03-20 |
| 2023-09-30 | $13.00K 10-Q · filed 2025-01-03 |
| 2023-06-30 | $17.00K 10-Q · filed 2024-08-15 |
| 2023-03-31 | $98.00K 10-Q · filed 2024-05-15 |
| 2022-12-31 | $196.00K 10-K · filed 2024-04-01 |
| 2022-09-30 | $262.00K 10-Q · filed 2023-11-14 |
| 2022-06-30 | $165.00K 10-Q · filed 2023-08-14 |
| 2022-03-31 | $211.00K 10-Q · filed 2023-05-15 |
| 2021-12-31 | $295.00K 10-K · filed 2023-03-31 |
| 2020-12-31 | $0.00 10-K · filed 2022-03-25 |
| 2019-12-31 | $0.00 10-K · filed 2020-03-30 |
| 2019-09-30 | $0.00 10-Q · filed 2019-11-14 |
| 2019-06-30 | $0.00 10-Q · filed 2019-08-14 |
| 2019-03-31 | $0.00 10-Q · filed 2019-05-15 |
| 2018-12-31 | $361.00K 10-K · filed 2020-03-30 |
| 2018-09-30 | $361.00K 10-Q · filed 2018-11-14 |
| 2018-06-30 | $361.00K 10-Q · filed 2018-08-14 |
| 2018-03-31 | $361.00K 10-Q · filed 2018-05-15 |
| 2017-12-31 | $361.00K 10-K/A · filed 2019-04-02 |
| 2016-12-31 | $0.00 10-K · filed 2018-04-02 |